关键词：人胰岛素市场；迅速增长；1型；2型糖尿病；肥胖；人口老龄化
摘 要：The global human insulin market is expected to grow rapidly during the forecast period. Factors such as an increase in population with type 1 and 2 diabetes and the rise in disease awareness contribute to this growth. In addition, a rise in obese as well as the aging population is expected to further propel market growth. However, factors such as stringent regulatory environment, low diagnosis rate of diabetes, market competition from local players, inconvenient ROA, and poor storage conditions will hamper the market.
目 录：

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Product profiles

PART 04: Market research methodology

Research methodology

Economic indicators

PART 05: Disease overview

Epidemiology

PART 06: Pipeline analysis

PART 07: Introduction

Key market highlights

PART 08: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 09: Market segmentation by type of insulin

Fast-acting insulin

Intermediate-acting insulin

Long-acting insulin

PART 10: Market segmentation by type of disease

PART 11: Geographical segmentation

PART 12: Market drivers

PART 13: Impact of drivers

PART 14: Market challenges

PART 15: Impact of drivers and challenges

PART 16: Market trends

PART 17: Vendor landscape

Competitive scenario

Market share analysis 2014

Other prominent vendors

PART 18: Key vendor analysis

Lilly

Novo Nordisk

Sanofi

PART 19: Appendix

List of abbreviation

PART 20: Explore Technavio